The Patent Finder

Neuralab Limited

Also on record
Records under this name other than patents Neuralab Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Neuralab Limited

PatentTitleStatus Expires Confidence
US 7,625,560Humanized Antibodies That Recognize Beta Amyloid Peptide
now held by Wyeth LLC
In force
 · High confidence
In forceHigh confidence
US 7,871,615Humanized Antibodies That Recognize Beta Amyloid Peptide
now held by Wyeth LLC
Term ended
Term ended Jun 19, 2024 · High confidence
Term endedTerm ended Jun 19, 2024High confidence
US 8,034,339Prevention and Treatment of Amyloidogenic Disease
conveyed to Elan Pharma International Limited - now held by Janssen Alzheimer Immunotherapy
Lapsed on the fee record
Ended Oct 11, 2023 · Low confidence
Lapsed on the fee recordEnded Oct 11, 2023Low confidence
US 9,051,363Humanized Antibodies That Recognize Beta Amyloid Peptide
Term ended
Term ended Jan 1, 2022 · Medium confidence
Term endedTerm ended Jan 1, 2022Medium confidence
US 7,790,856Humanized Antibodies That Recognize Beta Amyloid Peptide
Term ended
Ended no later than Nov 10, 2020 · Low confidence
Term endedEnded no later than Nov 10, 2020Low confidence
US 8,034,348Prevention and Treatment of Amyloidogenic Disease
conveyed to Elan Pharma International Limited - now held by Janssen Alzheimer Immunotherapy
Term ended
Ended no later than Sep 2, 2020 · Low confidence
Term endedEnded no later than Sep 2, 2020Low confidence
US 8,642,044Prevention and Treatment of Amyloidogenic Disease
conveyed to Elan Pharma International Limited - now held by Janssen Alzheimer Immunotherapy
Term ended
Term ended Sep 2, 2020 · Medium confidence
Term endedTerm ended Sep 2, 2020Medium confidence
US 8,227,403A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
Lapsed on the fee record
Ended Jul 24, 2020 · Medium confidence
Lapsed on the fee recordEnded Jul 24, 2020Medium confidence
US 6,913,745Passive Immunization of Alzhemer's Disease
Term ended
Ended no later than Jun 1, 2020 · Medium confidence
Term endedEnded no later than Jun 1, 2020Medium confidence
US 8,124,081Prevention and Treatment of Amyloidogenic Diseases
conveyed to Elan Pharma International Limited - now held by Neotope Biosciences Limited
Lapsed on the fee record
Ended Feb 28, 2020 · Low confidence
Lapsed on the fee recordEnded Feb 28, 2020Low confidence
10 of 69 records shown.
Pro members see all 69.
Pro members: see all 69 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited